Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
5.95
+0.15 (2.59%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Addex Therapeutics Employees
Addex Therapeutics had 3 employees as of December 31, 2025. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
$45,503
Profits / Employee
-$2,895,295
Market Cap
5.75M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 1 | 50.00% |
| Dec 31, 2024 | 2 | -21 | -91.30% |
| Dec 31, 2023 | 23 | -1 | -4.17% |
| Dec 31, 2022 | 24 | -2 | -7.69% |
| Dec 31, 2021 | 26 | -1 | -3.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| CollPlant Biotechnologies | 39 |
| AIM ImmunoTech | 21 |
| FibroBiologics | 15 |
| Soligenix | 14 |
| NuCana | 12 |
| Purple Biotech | 10 |
| Enveric Biosciences | 6 |
ADXN News
- 4 weeks ago - Addex Therapeutics (ADXN) Reveals Promising Preclinical Results on Sleep-Wake Regulation - GuruFocus
- 4 weeks ago - Addex Research Highlights MGlu7 Modulation As A Novel Pathway In Sleep And Stress Regulation - Nasdaq
- 4 weeks ago - Addex Therapeutics announces publication of new ADX71743 preclinical research - TheFly
- 6 weeks ago - Addex Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Addex Therapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Addex Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Addex Therapeutics Releases Q1 2026 Financial Results - AlphaStreet
- 6 weeks ago - Addex Records Wider Net Loss Of $1.7 Mln; Advances NTX-253 In Phase 1 For Schizophrenia - Nasdaq